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Rende (CS), ItalyABSTRACT Adenoviruses are commonly used in vitro as gene transfer vectors in multiple applications. Nevertheless, issues
such as low infection efficiency and toxicity effects on host cells have not been resolved yet. This work aims at developing a new
versatile tool to enhance the expression of transduced genes while working at low viral doses in a sequential manner. We devel-
oped a microfluidic platform with automatically controlled sequential perfusion stages, which includes 10 independent channels.
In addition, we built a stochastic mathematical model, accounting for the discrete nature of cells and viruses, to predict not only
the percentage of infected cells, but also the associated infecting-virus distribution in the cell population. Microfluidic system and
mathematical model were coupled to define an efficient experimental strategy. We used human foreskin fibroblasts, infected by
replication-incompetent adenoviruses carrying EGFP gene, as the testing system. Cell characterization was performed through
fluorescence microscopy, followed by image analysis. We explored the effect of different aspects: perfusion, multiplicity of infec-
tion, and temporal patterns of infection. We demonstrated feasibility of performing efficient viral transduction at low doses, by
repeated pulses of cell-virus contact. This procedure also enhanced the exogenous gene expression in the sequential microflui-
dic infection system compared to a single infection at a higher, nontoxic, viral dose.INTRODUCTIONThe precise control of in vitro viral transduction is highly
desirable in several applications, i.e., in the optimization
of gene therapies (1–3), RNA interference experiments
(4), induced pluripotent stem cell production (5), or for
promoting stem cell differentiation (6). Nonreplicating
adenoviral vectors (AdVs) are increasingly used for such
purposes, because they introduce transgenes into cells
without uncontrollable random integrations in host DNA
and minimizing other perturbations of cell homeostasis
(7). In addition, they are easy to manufacture and have the
ability to infect also quiescent cells (8). On the other
hand, transduction by AdVs suffers from low efficiency
(9), and using high viral doses to achieve sufficient trans-
duction induces cytotoxicity, as previously demonstrated
not only in vivo (7,10), but also in vitro (7,11–14), using
different types of primary cells and cell lines. Cytotoxicity
is dose-dependent, and in vitro studies do not show signifi-
cant effects on the cells at low multiplicities of infection
(MOIs) (11,12). MOIs are defined as the number of viral
particles per cell.
Chuck and Palsson (15) used convective flow conditions
to enhance virus-cell contact and increase the probability
of virus entrance into the cells. Furthermore, microfluidics
can improve the control over virus-mediated gene delivery
even at very low MOIs. In fact, microfluidic devices over-
come some of the limitations of conventional bench-topSubmitted June 17, 2012, and accepted for publication December 31, 2012.
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0006-3495/13/02/0934/9 $2.00systems, taking advantage not only of their high surface/
volume ratio but also of laminar flow in the microfluidic
channels (16). Microfluidics has already been used in
applications involving viral particles, especially in the
field of biosensors (for example, for infectious virus detec-
tion (17,18)). However, some devices were also developed
for novel interesting applications: to measure virus infec-
tivity and antiviral drug efficacy (19), for efficiently
studying virus inactivation (20), and for virus-blood cell
separation (21). Furthermore, a microfluidic bioreactor
for virus production (22), and a device for protein produc-
tion generating virus concentration gradients (23) were
designed.
The highly defined environment in a microfluidic system,
coupled with the possibility of easily automating its control,
makes simple to explore a huge range of experimental
conditions. However, a precise understanding of the phys-
ical and biological phenomena involved is needed for
a rational experimental design. Multiple mathematical
models describing viral infection have been developed on
different scales. Efforts to quantitatively describe viral
dynamics in vivo have been reviewed by Perelson (24).
More detailed computational models, based on in vitro viral
infection data, include works describing virus transport to
the cell surface (25,26), virus-cell interaction (25,27,28),
and intracellular viral trafficking (29,30).
Tayi et al. (31) developed a very exhaustive deterministic
mathematical model including the steps from virus transport
in the extracellular medium to viral transgene expression.
Although computationally more requiring, a stochastic
approach in modeling virus transduction dynamics is morehttp://dx.doi.org/10.1016/j.bpj.2012.12.049
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Seisenberger et al. (26) experimentally showed that viruses
move within the culture medium by Brownian motion and,
once they get to a cell surface, they have a certain proba-
bility of penetration through the membrane. Some of the
models mentioned above partly adopted a probabilistic
approach, but including only the discrete nature of viruses
and not of cells (25,27–29). Thus, they could not calculate
how viruses distribute within the cell population without
further assumptions, such as the approximation of a Poisson
distribution for the fraction of cells infected by a given
number of viruses (31).
In this work, we developed a useful methodology for the
accurate control of time-dependent gene delivery by AdVs,
by integrating experimental and theoretical analyses. We
realized a microfluidic platform to perform up to 10 parallel
independent experiments in a single miniaturized chip, with
accurate control of perfusion stages. Given this setup,
multiple operating conditions, in terms of mass transport
parameters and temporal profiles of virus delivery, could
be easily tested. Enhanced green fluorescent protein
(EGFP) was used as a reporter of cell infection for online
detection of the temporal evolution of the experiment. In
parallel, we developed a stochastic simulation algorithm
to theoretically study the viral transduction process. The
model accounts for the discrete nature of both cells and
viruses in a three-dimensional space. The computational
simulations show not only the percentage of infected cells,
but also the distribution of viral particles in the cell popula-
tion. With these tools, we studied the feasibility of perform-
ing efficient AdV transduction experiments at low viral
dose, by performing multiple sequential pulses of viral
transduction.MATERIALS AND METHODS
Cell culture
Human foreskin fibroblasts were expanded in gelatin-coated 75-mL flasks
with high-glucose Dulbecco’s Modified Eagle’s Medium (DMEM 41965;
Invitrogen, Carlsbad, CA), supplemented with 10% fetal bovine serum (In-
vitrogen) and 1% penicillin/streptomycin (Invitrogen). At 90% confluency,
cells were trypsinized with trypsin-EDTA 0.25% (Invitrogen), centrifu-
gated at 1200 rpm for 5 min, and resuspended in growth medium for
seeding.Adenoviral vectors
Replication-incompetent adenoviral vectors (AdVs) based on the Ad5
genome and lacking the E1 and E3 regions were constructed by homolo-
gous recombination in Escherichia coli using the AdEasy vector system
(Qbiogene, Carlsbad, CA). In these vectors, human cytomegalovirus
promoter was used to drive expression of EGFP. Transgenic adenoviral
vectors were propagated in E1-complementing HEK 293 cells, purified
by cesium chloride density centrifugation, and titrated by TCID50 CPE
endpoint assay according to the AdEasy production protocol (Qbiogene).
Viral vector stocks were stored at 2  108 PFU/mL concentration in 10%
glycerol at 80C until use.Microfluidic device
Themicrofluidic platform contains 10 independent channels for cell culture,
each connected to a built-in medium reservoir of ~70 mL, and to a syringe
pump system for fluid handling. A schematic representation of themicroflui-
dic system is shown in Fig. 1 A, and its dimensions are reported in Fig. 1 B.
The microfluidic chip was fabricated by common soft-lithographic tech-
niques (32). The master was photolitographically patterned by using SU8-
2100 negative photoresist (MicroChem, Newton, MA) to obtain a final
thickness of 200 mm, according to manufacturer’s indications. A PDMS
mold was obtained by casting a premixed 10:1 ratio prepolymer and curing
agent solution (Sylgard 184 kit; Dow Corning, Midland, MI) on the silicon
wafer. After curing at 70C for 2 h, the PDMSmold was cut, peeled off, and
punched with a 21G stainless steel needle (Small Part Inc., Logansport, IN)
to obtain inlet/outlet holes. The PDMS mold was assembled and sealed to
a 50  75 mm cleaned glass slide by plasma bonding. Ten independent
medium reservoirs, one for each channel, were obtained by sealing an addi-
tional PDMS block to the top of the device by plasma bonding. The assem-
bled device was cleaned with isopropanol (Sigma-Aldrich, St. Louis, MO)
and sterilized in an autoclave. A syringe pump with a 10-syringe rack (Har-
vard Pump; Harvard Apparatus, Holliston, MA) was used to control the
medium flow rate from the reservoirs into the microfluidic channels. We
also used 0.5 ID Tygon tubings (Cole-Parmer, Vernon Hills, IL) and 21G
stainless-steel needles with a polypropylene luer (Microtest, Taipei,
Taiwan) to connect the microfluidic chip to the syringes. The entire exper-
imental setup is shown in Fig. 1 C.Viral transduction experiments
Before cell seeding, themicrofluidic channels were coatedwith gelatin 0.6%
and incubated at 37C and 5%CO2 atmosphere for 24 h. The cell suspension
was injected into each channel and themicrofluidic chip was incubated over-
night at 37C and 5% CO2 atmosphere without perfusion. We used a proper
cell seeding concentration to achieve confluent cell culture (corresponding
to a final cell density of 150 cell/mm2) at 24 h after seeding. Then, discon-
tinuous medium refill was achieved by automatically controlling the multi-
channel syringe pump through LabView 8.2 (National Instruments, Austin,
TX), without further manual intervention. The pump was programmed to
run every 3 h for 4 min with a flow rate of 3 mL/min for medium change.
Twenty-four hours after cell seeding, AdV transduction was performed.
The viral stock solution was thawed and diluted with culture medium to the
final concentration. Medium perfusion into the microchannels was per-
formed with different dynamics through the automated syringe pump that
aspirates medium from the channels. Each experimental condition was
tested in at least two microfluidic channels in parallel. Parallel control
experiments were performed in microchannels supplied with AdV-free
medium during viral transduction.
The conventional bench-top system used as a reference is a 24-well tissue
culture plate (Becton Dickinson, Franklin Lakes, NJ). Cells were seeded
and cultured for 24 h in 1 mL medium. Then, medium was replaced with
200-mL AdV-containing medium at different concentrations. After incuba-
tion for tf ¼ 90 min at 37C and 5% CO2, medium was changed again with
1 mL virus-free medium that was kept until the end of the experiment. Each
experimental condition was tested in at least three wells in parallel. Three
wells were used as controls in every experiment and were supplied with
medium without AdVs during viral transduction.Cell characterization
Cell count andEGFPexpressionweredetected in situ byfluorescencemicros-
copy (DMI 6000-B; Leica Microsystems, Milan, Italy). Cell nuclei were
stained by incubating live cells with 2mg/mLHoechst 33342 dye (Invitrogen)
in culture medium for 30 min. Bright-field and fluorescence images were
taken at 10 magnification, with exposure, gain, and intensity parametersBiophysical Journal 104(4) 934–942
FIGURE 1 Microfluidic experimental setup. (A)
Three-dimensional graphical representation of
the microfluidic platform composed of 10 parallel
independent channels. (B) Lateral section of one
channel indicating its geometrical dimensions.
(White arrow) Flow direction. (C) Overview of the
whole system: the microfluidic platform (top view
on the left) is placed in a biological incubator during
experiments, and medium perfusion (from left to
right) in every channel is provided by a set of
syringe pumps, whose temporal pattern of flow
rate is automatically controlled. (D) Images of the
whole microfluidic channel taken with a fluores-
cence microscope to detect EGFPþ cells and cell
nuclei.
936 Luni et al.equal to the respective control in each culture system. Every channel was
entirely captured for the microfluidic system (Fig. 1 D), and three randomly
chosen positions in every well were acquired for the multiwell plate.
The cell density and the percentage of EGFPþ cells were quantified by
image analysis, using the software MATLAB (The MathWorks, Natick,
MA), as previously described in Cimetta et al. (16). We performed this
image analysis using different values for the threshold of fluorescence
intensity, f, that discriminates between EGFP positive and negative cells.
In this way, we could quantify the number of cells expressing EGFP at
different levels, and not just the number of EGFPþ cells.Stochastic simulation algorithm
The mathematical model developed includes the extracellular virus trans-
port in the culture medium (by diffusion and convection) and the entrance
of viruses into the cells. Convective transport, present only in the microflui-
dic channels during filling and emptying, occurs in the x direction (Fig. 2 A)
with a parabolic velocity profile, vx(y).
The geometry simulated includes the whole culture channel for the mi-
crofluidic system. For the conventional multiwell plate, a representative
subvolume of the well (1.73-mm2 bottom area), having the same height
as the medium during viral transduction (H ¼ 1 mm), was simulated.
Choosing a time step Dt for the simulation, the position (xi, yi, zi) of the i
th
virus at time t þ Dt, given that at time t, was computed according to the
Euler scheme of discretization for the Smoluchowski stochastic differential
equation:8<
:
xiðt þ DtÞ ¼ xiðtÞ þ vxðyÞ$Dt þ
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
2$D$Dt
p
$xx;i;
yiðt þ DtÞ ¼ yiðtÞ þ
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
2$D$Dt
p
$xy;i;
ziðt þ DtÞ ¼ ziðtÞ þ
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
2$D$Dt
p
$xz;i;
(1)
where D is the diffusion coefficient of the virus in medium, and xx,i, xy,i, and
xz,i are normally distributed random variables with zero mean and unit vari-
ance. The model was solved in MATLAB.Biophysical Journal 104(4) 934–942In both systems, cells were randomly distributed at the bottom within
a regular square grid (Fig. 2 A), to have the same density as in the experi-
ments. The grid size was equal to dcell ¼ 65.7 mm, to have squares of the
same cell surface area as that experimentally measured (4300 5 560
mm2). We neglected cell division because contact inhibition prevails at
the cell seeding density used, as we verified during the experiments (see
the Supporting Material).
In the simulated subdomain of the multiwell plate, at time t ¼ 0 viruses
were randomly placed within the three-dimensional medium volume to
match the experimental concentration. Instead, in simulating the microflui-
dic system, virus concentration was null at time t ¼ 0, and then viruses
progressively entered with the flowing medium, at the appropriate concen-
tration, distributed randomly on the inlet section surface.
Virus entrance into the cells was described in the model as a partially
adsorbing boundary condition at y ¼ 0, because not all cell-virus contacts
are successful for introducing the virus into the cell (26). Formally, the
probability that the ith virus enters a cell in the time span Dt is given by
P1
ﬃﬃﬃﬃﬃ
Dt
p
, if the virus has yi(t þDt)% 0, where P1 is a model parameter; or
P1
ﬃﬃﬃﬃﬃ
Dt
p
$exp
yiðtÞ$yiðt þ DtÞ
ðD$DtÞ

;
otherwise. More details on this boundary condition are provided in the Sup-
porting Material and in Erban and Chapman (33). The other boundaryconditions were set as reflection, a part for the open boundaries at medium
inlet and outlet of the channel. We assumed that cells infected by at least
one virus, then express EGFP.Model parameter values
The model parameter values are summarized in Table 1. The parameters
related to system geometries and operative variables were fixed to match
the experimental conditions. The value of the diffusion coefficient (D)
was taken from Oliver et al. (34). Parameter P1 was derived by fitting the
FIGURE 2 Stochastic model processes and
parameter fitting. (A) Graphical representation of
the phenomena included in the stochastic model:
medium convection with parabolic velocity profile,
virus Brownian motion in three-dimensional space,
and virus entering a cell with a certain probability
when it gets on its surface. Plane x-z represents the
bottom surface of the channel where cells are
randomly distributed within a regular square grid.
(B) Results of model parameter fitting. Experimen-
tally, transduction was performed in a 24-well
plate using 200 mL of virus-containing medium
for 90 min. Cell concentration was 130 cell/mm2.
(Red error bars) Percentage of cells expressing
EGFP 24 h after AdV transduction as a function of virus concentration, mean5 standard deviation values obtained in independent experiments, each per-
formed in double or triple. Simulations by the stochastic model reproduce the experimental conditions. In the model, EGFPþ cells are given by cells infected
by at least one virus. (Black dots) Model outcome, each dot is obtained from one simulation at the given virus concentration. One-hundred simulations were
performed at each condition. (Black line) Simulation mean results.
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Specifically, we minimized the following cost function, 4,
4 ¼
X
i

xmodi  xexpi
2
ðsexpi Þ2
; (2)
where superscripts mod and exp refer to model and experimental values,
respectively; and xi and si are the mean and standard deviation of the
percentage of EGFPþ cells, obtained at the ith virus concentration. Param-
eter fitting results are shown in Fig. 2 B in terms of both mean and standard
deviation due to experimental uncertainty and model stochasticity.RESULTS AND DISCUSSION
Spatial heterogeneity in microfluidics
To perform transduction experiments in a microfluidic
channel, virus-containing medium needs to be perfused
over the cells. As medium flows from inlet to outlet, it
gets depleted of the viruses that enter the cells in between;
hence, cells located in the downstream part of the channel
are exposed to a lower MOI than those near the inlet. We
computationally investigated how relevant is spatial hetero-
geneity in a perfused channel.
To begin, we simulated a channel perfused with a constant
flow rate of 0.1 mL/min (Peclet number equal to 300). TheTABLE 1 Parameter values of the model
Parameter Value
Cell equivalent size (dcell) 65.7 mm
Culture volume height (H) 1000 mm (multiwell)
200 mm (microfluidics)
Culture volume length (L) 1314 mm (multiwell)
17  103 mm (microfluidics)
Culture volume width (W) 1314 mm (multiwell)
1500 mm (microfluidics)
Virus diffusion coefficient (D) 3.67 mm2/s
AdV-cell interaction constant (P1) 0.0079 s
0.5
Cell seeding density (rcell) 130–150 cell/mm
2
AdV transduction duration (tf) 90 min
Simulated time step (Dt) 0.16 smedium entering the system had a virus concentration cor-
responding to an instantaneous MOI of 20 in the system,
given a cell density of 130 cell/mm2. We defined the MOI
as instantaneous because it represents the number of viruses
per cell within the channel at a given time. On the other
hand, a global MOI can be defined by considering the total
number of viruses entering the system during the whole time
span of infection. The time of perfusion was set to 90 min,
because it is the time (tf) required for a viral particle to travel
a distance s ¼ 200 mm (the channel height) by Brownian
motion, calculated from the Einstein’s relation,
tf ¼ s
2
2$D
; (3)
where D is the diffusion coefficient of the virus in medium.
One-hundred stochastic simulations were performed. We
verified that the whole channel was perfused by calculating
that, at the flow rate simulated, 90 min correspond to 1.7
residence times.
The length of the channel was divided in 10 sectors, and
in each sector the percentage of EGFPþ cells, i.e., of cells
infected by at least one virus, was calculated. The results
are shown in Fig. 3, A (top) and C. The percentage of posi-
tive cells in the last sector, near the outlet, is ~20% less than
that in the first sector, at the inlet. Thus, spatial heteroge-
neity can be a relevant phenomenon introduced by perfusion
that affects the quality of the resulting cell population. We
also studied this aspect at different MOIs in the Supporting
Material. Although at high MOI all the cells are infected, we
verified that heterogeneity is still present in terms of virus
distribution within the cell population, producing a gradient
of infection level along the channel (Fig. 3 A, bottom).
To avoid this issue, we developed a different strategy for
providing virus-containing medium to the cells, based on
discontinuous perfusion. Keeping the same system geom-
etry, cell density, and virus concentration as in the previous
case, we simulated a perfusion of 2 min at a flow rate of
6 mL/min, 90 min without perfusion, and then 2 minBiophysical Journal 104(4) 934–942
FIGURE 3 Computational study of spatial
heterogeneity in the microfluidic system. (A and
C) Results of stochastic simulations of continuous
channel perfusion with a flow rate of 0.1 mL/min
for 90 min. (B and D) Results of simulations
of discontinuous perfusion: 2 min of inflow at
6 mL/min, 90 min without perfusion, and 2 min
of outflow at 6 mL/min. (A and B) Bottom of a
microfluidic channel: the EGFPþ cells (top) and
the number of virus/cell (bottom) are shown; color
meaning is explained in color bars in panel A.
(Black arrow) Flow direction. (C and D) (Dotted
lines) Percentage of EGFPþ cells in each of the
10 equal sectors of the channel. (Error bars)
Mean 5 standard deviation of 100 simulations.
(A–D) Cell concentration is 130 cell/mm2, instan-
taneous MOI is 20.
938 Luni et al.of outflow. We verified that the shear stress occurring at
6 mL/min, ~6.8 mPa, is well below the threshold of cell
damage (35), and can be effectively used during biological
experiments. As shown in Fig. 3, B and D, by performing
the infection under these discontinuous conditions, spatial
heterogeneity is within the stochastic noise of the system.
EGFPþ cells are homogeneously distributed along the
channel, because the 2 min of inflow and outflow negligibly
affect the overall outcome.
The whole channel is filled in less than a minute at this
flow rate and virus adsorption does not occur fast enough
to produce a gradient in the infection level along the
channel. On the contrary, in the previous case, channel
filling took ~50 min, a time of the same order of magnitude
of the characteristic time of adsorption. Other conditions of
flow were simulated confirming this hypothesis, whose
results are presented in the Supporting Material. Further-
more, perfusion conditions may also affect the overall cell
quality by changing the accumulation of endogenous factors
in cell microenvironment, as recently reported in Moledina
et al. (36). A discontinuous flow protocol better preservesBiophysical Journal 104(4) 934–942cell microenvironment while ensuring a homogenous trans-
fection along the microfluidic channel.
The homogeneity of transfection was confirmed also by
experimental observations in our microfluidic system, as
shown in the Supporting Material. All the results presented
in the next sections, both computational and experimental,
are obtained applying a discontinuous flow.Effect of MOI after single viral infection
We computationally investigated the effect of MOI on the
percentage of EGFPþ cells and the infecting-viruses distri-
bution.We simulated the transduction process in a microflui-
dic channel for a cell density of 150 cell/mm2 at four
different MOIs: 20 (equal to a concentration of 15,000
PFU/mL), 10 (7500 PFU/mL), 5 (3750 PFU/mL), and 1
(750 PFU/mL). Fig. 4 shows the resulting probability and
complementary cumulative distributions of the percentage
of cells infected with different numbers of viruses, as
calculated by the model. Despite the spatial homogeneity
of performing AdV transduction in microfluidics under
FIGURE 4 Computational study of viral transduction at different MOIs.
Results of 100 stochastic simulations at MOI 1 (A), 5 (B), 10 (C), and 20
(D), in a microfluidic channel under discontinuous flow conditions, at
a cell concentration of 150 cell/mm2. Bar plots represent the percentage
of EGFPþ cells infected by n viruses. (Solid lines) Complementary cumu-
lative distribution. In each plot the percentage of EGFPþ cells (i.e., cells
infected by at least one virus) is also indicated. (Error bars) Mean5 stan-
dard deviation of the 100 simulations.
FIGURE 5 Experimental study of viral transduction in the microfluidic
platform at different MOIs. (A) Comparison of experimental (subscript
exp) and simulated (subscript mod) percentage of EGFPþ cells. Marker
colors are defined by legend in panel B. (B) Complementary cumulative
distribution of the percentage of EGFPþ cells showing a fluorescence inten-
sity> f (see Cell Characterization in main text). (C) Probability distribution
of the percentage of EGFPþ cells showing a fluorescence intensity f at MOI
1, 5, 10, and 20 (from left to right). (A–C) The percentage of cells express-
ing EGFP was detected 24 h after AdV transduction. Cell concentration was
150 cell/mm2. (Error bars) Mean5 standard deviation values obtained in
independent experiments, each performed in double or triple.
Viral Transduction in Microfluidics 939discontinuous flow (Fig. 3), the discrete nature of cells and
viruses, and how they are randomly distributed on the
bottom surface and in the medium volume, respectively
can still generate a heterogeneous cell population for the
number of viruses infecting each cell. At MOI 1, almost
all the cells infected have only one virus, but at higher
MOIs, heterogeneity is visible in the cell population (Fig. 4).
Furthermore, the effective mean number of viruses per
cell is much lower than the theoretical one, given by the
MOI, confirming previous work in Andreadis et al. (37).
For example, at MOI 20 the mean number of viruses per
cell is only between 3 and 4 (Fig. 4 D). Fig. 4 shows also
the percentage of cells infected by at least one virus, i.e.,
of EGFPþ cells, according to the hypotheses described in
Materials and Methods. As expected, the efficiency of the
infection process increases at higher MOIs.
Experimentally, given the very great surface/volume ratio
of microfluidic systems, we first verified that there were not
substantial AdV losses due to binding on the surfaces of the
channels. The results are reported in the Supporting Mate-
rial. Then, we performed experiments of viral transduction
in the microfluidic platform under the same conditions
simulated above and characterized the cell population at
24 h after the beginning of infection. We assumed that this
period of time is sufficient for infected cells to express
EGFP protein, as reported previously in de Martin et al.
(38). The very good agreement between the percentages
of EGFPþ cells obtained from experimental data and pre-
dicted by the model (Fig. 5 A), shows the stochastic model
fairly describes the overall infection process within the mi-
crofluidic platform. This result is particularly relevant
considering that all extra- and intracellular biological
phenomena of viral infection (excluding those related toextracellular viral particle mass transport) are lumped in
an overall limiting step, whose parameter was obtained by
experimental data collected under static conditions in a mul-
tiwell plate.
We investigated the experimental heterogeneity of the
cell population as for the EGFP produced at the single-
cell level. We quantified the intensity of fluorescence, f, of
each cell by image analysis, as described in Materials and
Methods. The results are shown in Fig. 5, B and C, in terms
of complementary cumulative distribution and of proba-
bility distribution, respectively. Besides increasing the
percentage of cells expressing EGFP, AdV transduction per-
formed at higher MOIs enhances the amount of exogenous
RNA and consequently the amount of EGFP produced by
single cells. This could be related to the increase in the
number of viruses infecting each cell, as explored computa-
tionally (Fig. 4). However, multiple other processes overlap
(such as virus intracellular transport, cell cycle, regulation
of transcription and translation), and a straight correlation
between the two variables, number of virus per cell, and
intensity of cell fluorescence, is not possible. A simplified
model that correlates these two variables is presented in
the Supporting Material.Multiple pulses of viral transduction
Thanks to the developed technology, the same efficiency of
infection of cell culture could be obtained by infecting cells
several times at low MOI, thus preventing any cytotoxicBiophysical Journal 104(4) 934–942
940 Luni et al.effect due to external viral particles. For this reason, we
explored the possibility of performing multiple sequential
pulses of infection at low viral doses to increase protein
expression over time and avoid the cell toxicity of high
MOIs. We compared the outcome of a single viral transduc-
tion at MOI 20 (still low enough not to be toxic) with that of
two infections at MOI 10, and of four infections at MOI 5.
The total number of viruses entering the system was thus the
same, but three different regular temporal sequences were
used (Fig. 6). We simulated these three scenarios with the
stochastic model, and found that theoretically the same
outcome is achievable with a multipulse strategy, in terms
of percentage of EGFPþ cells and of the distribution of
the number of viruses per cell (Fig. 6).
Taking advantage of the precise automation of flow rate
control in themicrofluidic platform, we performed the exper-
iment corresponding to the theoretical simulations described
above. We infected the cells at time 0 and the other time-
points given in the three protocols, using a discontinuous
flow strategy, i.e., 2 min of virus-containing medium flow
(or virus-free medium in the channels not to be infected),
90 min of infection under static conditions, and 2 min of
virus-free medium flow. We monitored the level of cell
EGFP expression 24 h after each infection, i.e., at the
following time points: 24, 36, 48, and 60 h after the first infec-
tion. The results are presented in Fig. 7, in terms of proba-
bility and complementary cumulative distributions. Fig. 7
D shows a comparable EGFP gene expression with the three
protocols after 48 h,while at 60 h channels treatedwithmulti-
pulse viral transduction at lower MOIs show a higher
percentage of cells being more fluorescent (Fig. 7 D).Biophysical Journal 104(4) 934–942In this experiment, the maximum MOI used was 20. As
previously verified, this is below the threshold of cytotox-
icity, identified approximately at MOI 50 (11,12). These
conditions, coupled with a constant cell density due to
contact inhibition, are useful to detect the effect of a sequen-
tial infection strategy at net of cell division and death
phenomena, which are also not included in the stochastic
model. Overall, a comparison between the percentages of
EGFPþ cells (Fig. 7 D) shows the feasibility of performing
sequential viral transduction experiments without loss of
efficiency, and highlights the importance of the multipulse
infection strategy in cases when cytotoxicity is a concern.
We performed sequential transduction experiments also at
very high MOIs, as reported in the Supporting Material,
and the results strongly support the reduction in cytotoxicity
achievable.
Furthermore, the higher EGFP expression achieved after
repeated infections at MOI 5 than after a single one at
MOI 20, confirms the complexity of gene expression regu-
lation, which is not linearly dependent on the amount of
exogenous DNA inserted. Thus, the sequential infection
strategy may be a useful means also to study complex
dynamics of gene expression in a highly controlled system.CONCLUSIONS
Viral vectors are increasingly used to insert exogenous
genetic material in cells. Low efficiency of infection at
low MOIs and cytotoxicity at high MOIs are two critical
limitations affecting the process. In this work, we showed
the feasibility of performing sequential infections at lowFIGURE 6 Multiple viral transductions strategy
and computational results. Repeated 90-min AdV
infections with MOI 20 (A), 10 (B), and 5 (C), at
the time-points indicated. (Insets) Model predic-
tions of the percentage of EGFPþ cells infected
by n viruses at the end of each pulse of infection.
Cell concentration was 150 cell/mm2. (Error
bars) Mean 5 standard deviation of 100 simula-
tions at each condition.
FIGURE 7 Results from experiments of multiple viral transductions within the microfluidic platform. AdV transduction timing followed the strategy
shown in Fig. 6: one infection at MOI 20 (A and blue line in D), two infections at MOI 10 (B and red line in D), and 4 at MOI 5 (C and green line in
D). EGFPþ cell fluorescence intensity, f, was measured at 24, 36, 48, and 60 h after the first infection. Cell concentration was 150 cell/mm2. (Error
bars) Mean5 standard deviation of experiments repeated twice. (A–C) Probability distribution of the percentage of EGFPþ cells showing a fluorescence
intensity f, and (D) associated complementary cumulative distribution.
Viral Transduction in Microfluidics 941viral dose with high efficiency, taking advantage of micro-
fluidic technology to provide a highly defined temporal
control over the cell culture environment.
We coupled the experiments with a theoretical analysis
through a stochastic model to follow the dynamics of virus
entrance into the cells under continuous and discontinuous
flow conditions. In particular, being discrete in its descrip-
tion of viruses and cells, the model can recapitulate also
the heterogeneity in the cell population without further
assumptions.
Under the simplifying hypotheses of the model, one
infection at high viral dose and multiple at low doses, using
the same overall amount of viruses, should give the same
outcome in terms of distribution of viruses in the infected
cell population. However, we also found experimentally
that, compared to a single infection at high MOI, performing
multiple low-dose infections affects the gene expression
profile of the resulting cell population. Thus, the strategy
developed to perform time-controlled multipulse infections,
in addition to reducing viral toxicity, could be a powerfultool to investigate the dynamic complexity of the expression
of exogenous genes using a highly controlled system.SUPPORTING MATERIAL
Nine figures, one table, and Ref. (39) are available at http://www.biophysj.
org/biophysj/supplemental/S0006-3495(13)00038-6.
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